Chesaning, Mich. (February 14, 2019)—Wana Brands’ consistent and reliable Wana Sour Gummies are now available to Michigan’s medical marijuana program through an exclusive partnership with High Life Farms. Nearly 300,000 Michigan residents already possess a medical marijuana card making it the second largest medical marijuana patient population in the United States and more than three times the size of Colorado’s medical marijuana program. With a population of 9.9 million, Michigan is the first Midwest state to legalize adult-use cannabis. The $1.7 billion adult-use program is expected to come online in 2020.
“Michigan has a significant number of residents already participating in the state’s medical marijuana program,” noted Wana CEO Nancy Whiteman. “Wana Brands wants to provide Michigan marijuana patients access to America’s No. 1 edible. We selected High Life Farms as our Michigan partner because they are proven operators with a strong team and a great facility. Now that we’re established with a great partner and available in medical dispensaries, we will also be ready to serve the state when adult-use comes online.”
Wana flavors and ratios available in Michigan include Watermelon Hybrid (100mg per package, 10 pieces); Blueberry Indica (100 mg per package, 10 pieces); and Mango Sativa (100 mg per package, 10 pieces). Known for consistent dosing, Wana gummies are handcrafted and infused with high-quality tincture during the cooking process to ensure the best tasting, highest quality, consistent gummie on the market. Wana gummies are made with fruit pectin, not gelatin. A specially selected fruit pectin gives Wana Sour Gummies their amazing texture and makes them vegan. All Wana products are made with gluten-free ingredients and taste like real fruit, thanks to all-natural flavors and colors. Wana Gummies also have no sorbitol or mineral oil, both of which can cause stomach upset. Wana expects to launch its line of Wana Drops, WanaCapsXR and Wana Disposable Vape products in Michigan by 2020.
Michigan’s medical marijuana program currently allows for conditions including cancer, ALS, Crohn’s Disease, epilepsy, glaucoma, HIV/AIDS, seizures, multiple sclerosis and Parkinson’s disease. With availability to medical patients in Michigan, Wana Brands’ continues expansion from its Colorado headquarters. The Company’s consistent and potent medical marijuana products are also available in Colorado, Arizona, Nevada, Oregon and Illinois dispensaries, with Florida and Ohio among the states imminently coming online. Wana Brands expects to expand into California, Maryland, Pennsylvania and internationally in Canada through 2020. Wana Brands is the No. 1 infused cannabis brand in the United States, selling more units and dollars than any other cannabis products company, according to a November 2018 report from BDS Analytics.
Wana Brands: Enhance Your Life.
Included in the 2018 Inc. 5000 list at #1087 and boasting a three-year growth rate of 455%, Wana Brands is the No. 1 edibles brand in the United States, with more units and dollars sold than any other brand, according to BDS Analytics. Wana leads the industry in quality, consistency and potency, featuring a carefully curated line of edibles, including market-leading gummies and WanaCapsXR, a family of extended-release cannabis capsules that provide symptom relief for up to 12 hours. Wana products are available in Colorado, Arizona, Oregon, Nevada and Illinois. Wana is currently onboarding in Florida and Michigan to serve medical marijuana patients in those markets by end of 2019. The Company expects to enter California, Maryland, Ohio, Pennsylvania, Oklahoma, Missouri, Massachusetts, New Jersey and internationally in Canada by 2020. For more information or to subscribe to Wana’s e-newsletter, visit www.wanabrands.com.
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers